Nerandomilast | m-entrepreneurship.com

Product Name :
Nerandomilast

Search keywords :
PDE4B

drugId :
null

Target Vo:
Phosphodiesterase 4B

Target Vo Short Name :
PDE4B

Moa_Name:
Phosphodiesterase 4B inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
C.H. Boehringer Sohn Ag & Co. Kg

Active Company_Name :
Boehringer Ingelheim (China) Investment Co Ltd

Active Indication_Name:
Pulmonary Fibrosis

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 3 Clinical

China Highest Status:
Phase 3 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Enfortumab vedotin-ejfv (solution) site
Naptumomab Biological Activity
CaMKII alpha Antibody: CaMKII alpha Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 54 kDa, targeting to CaMKII alpha. It can be used for WB,IP,FC,IHC-P assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts